Tudor Investment Corp
COGT icon

Tudor Investment Corp’s Cogent Biosciences COGT Stock Holding History

Tudor Investment Corp’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-159,942
Closed -$5.91M – 3715
2025
Q4 		$5.68M Buy
+159,942
New +$4.5M 0.01% 1077
2025
Q2 		– Sell
-42,722
Closed -$256K – 3324
2025
Q1 		$256K Buy
42,722
+25,903
+154% +$203K ﹤0.01% 2702
2024
Q4 		$131K Buy
+16,819
New +$168K ﹤0.01% 2893
2024
Q3 		– Sell
-42,532
Closed -$359K – 2757
2024
Q2 		$359K Buy
+42,532
New +$323K ﹤0.01% 1949
2024
Q1 		– Sell
-58,031
Closed -$341K – 2304
2023
Q4 		$341K Buy
58,031
+11,060
+24% +$84.8K ﹤0.01% 1977
2023
Q3 		$458K Buy
46,971
+30,543
+186% +$362K ﹤0.01% 1719
2023
Q2 		$195K Sell
16,428
-23,645
-59% -$271K ﹤0.01% 2235
2023
Q1 		$432K Buy
40,073
+5,467
+16% +$69.9K 0.01% 1708
2022
Q4 		$400K Buy
+34,606
New +$429K 0.01% 1728

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Tudor Investment Corp's COGT Position: Q1 2026 in Review

Tudor Investment Corp sold out of Cogent Biosciences (COGT) in Q1 2026, closing a stake of 159,942 shares — an estimated $5.91M sold.

Tudor Investment Corp first reported a position in COGT in Q4 2022 and held it in 9 quarters. The position peaked at $5.68M in Q4 2025. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Tudor Investment Corp reported no remaining Cogent Biosciences position as of Q1 2026 after selling out during the quarter.
  • Tudor Investment Corp sold 159,942 Cogent Biosciences shares in Q1 2026, an estimated $5.91M.
  • Tudor Investment Corp first reported a position in Cogent Biosciences in Q4 2022 and held it in 9 quarters.
  • Tudor Investment Corp's Cogent Biosciences position peaked at $5.68M in Q4 2025.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.